Meyer Cancer Center
Academic Department
Research
administers grant
-
A multi-omics, single-cell toolkit to study disrupted hematopoietic differentiation in clonal hematopoiesis
-
Advancing the therapeutic landscape for Chronic Myelomonocytic Leukemia (CMML)
-
BPTF-mediated gene regulation in prostate cancer
-
BWF 2015 Career Award for Medical Scientists
-
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer
-
Bridging predictive models and precision immunotherapies
-
Center for Integrated Cellular Analysis
-
Characterization of mpMRI Features Associated with Persistence and Recurrence of Prostate Cancer After Partial Gland Ablation
-
Characterizing stem cell-like B cell subpopulations and dissecting their role in tumorigenesis
-
Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit
-
Clinical identification and targeting of non-neuroendocrine lineage plasticity in castration-resistant prostate cancer
-
Collaborative genomic alterations and transcriptional control in prostate cancer
-
Combing omics and imaging approaches to dissect critical regulatory proteins and enhancer hierarchies during pluripotent state transitions
-
Computational Methods for Identifying Non-Coding Cancer Drivers
-
Computational and experimental methods for scalable identification of oncogenic non-coding regions
-
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer
-
DNA Vaccines Against Cancer and Infectious Organisms
-
Deciphering differentiation hierarchies, heritability and plasticity in gliomas via single-cell multi-omics.
-
Deciphering heritability, plasticity and differentiation trajectories in gliomas via single-cell multi-omics
-
Deciphering the fitness determinants of clonal mosaicism
-
Deciphering the pathobiological mechanisms of dietary fat sensing in breast cancer
-
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy
-
Defining Evolutionary Trajectories Driving Prostate Cancer Metastases
-
Defining the impact of Kras mutational heterogeneity on the tumor microenvironment in pancreatic cancer
-
Defining the role of DNA methylation modifier mutations in reshaping blood differentiation topology
-
Determining Metastatic Drivers of Pten/p53-Loss-Driven Prostate Cancer Using Evolving DNA Barcodes
-
Determining and Targeting Evolutionary Trajectories Driving Bladder Cancer
-
Developing Novel Therapeutic Approaches for Classical and Variant Hairy Cell Leukemia (Core 2)
-
Developing Novel Therapeutic Approaches for Classical and Variant Hairy Cell Leukemia (Project 1)
-
Differential role of different NAD+ kinase Isoforms in melanoma metastasis
-
Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens
-
Dissecting the role of folate deficiency in lung cancer development and genomic instability
-
Enhancing Breast Cancer Therapy by Inhibiting the Adenosine Receptor and Oxygen Consumption
-
Enterome Services Agreement
-
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
-
Evaluation of Transperineal Biopsy under Local Anesthesia, a Novel approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
-
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes
-
Experimental And Preclinical Modeling Of NUP98-Rearranged Acute Leukemia
-
Folate deficiency as a source of genotoxic formaldehyde in cancer
-
Functional Dissection of Regulatory Myeloid Cells in Microbe-Immune Crosstalk in Skin
-
Gene regulatory networks in early lung epithelial cell fate decisions
-
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
-
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
-
High-parametric flow cytometry cell sorter for human immunology studies.
-
Identifying acquired vulnerabilities driven by lineage plasticity and drug resistance in CRC
-
Identifying and targeting 3D regulatory nodes that maintain glioblastoma programs.
-
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
-
Imaging tumor and T cell responses to metabolic and immune modulation
-
In Vivo Base Editing for Precision Oncology Models
-
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
-
Interrogation of the chromatin landscape to drive maturation of hPSC-derived skeletal muscle.
-
Investigating novel KRAS inhibitors effects on the tumor-immune responses and integration of KRAS inhibition with immune based therapies.
-
Investigating the role of propionate metabolism in cell senescence and aging
-
Ludwig Collaborative Laboratory
-
Lymphoma Scientific Research Mentoring Program (LSRMP)
-
MSK Immuno-Oncology for the Translational Researcher Short Course
-
Mark Foundation Emerging Leader Award
-
Mechanism-Based Approach for Combination Therapies with Immune Modulation for Management of Patients with Urothelial Cancers of the Upper Urinary Tract
-
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
-
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
-
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
-
Mosaic: post-zygotic mutations in vascular and lymphatic developmental disorders.
-
Mutations in epigenetic modifiers lead to alternative splicing in clonal hematopoiesis
-
New mechanisms governing skin tissue residency memory T cells
-
Nonclinical Research Agreement - BMS
-
Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis
-
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
-
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell Lung Cancer
-
Organizational principles and functional role of 3D enhancer hubs in cell fate decisions
-
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)
-
Precision, plasma-only, melanoma ctDNA residual disease monitoring
-
Propionate metabolism and cancer
-
Prostate Cancer Comparative Outcomes of New Conceptual Paradigms for Treatment (PC CONCEPT)
-
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
-
Randomized Trial Comparing Transperineal vs. Transrectal MRI-targeted Prostate Biopsy
-
Research Scholar Grants
-
Revolution Medicines, Inc. Biopharma
-
Signal Transduction to P70 S6 Kinase 1
-
Single-cell multi-omics to link clonal mosaicism (CM) genotypes with chromatin, epigenomic, transcriptomic and protein phenotypes
-
Sponsored Research Agreement - Merghoub Lab
-
Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function
-
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells
-
Studying the role of macrophages and gluconeogenesis in the regulation of Mycobacterium tuberculosis persistence in a mouse model of latency
-
Targeting BRCA1-mutant breast cancer cells with folate and vitamin C
-
Targeting BRCA1/2-deficient cancers with folate and vitamin C
-
Targeting immune evasion in gastroesophageal cancer
-
The role and regulation of the selenocysteine proteome in melanoma metastasis
-
The role of NAGK cysteine deprotonation in nutrient stress and cancer progression
-
Tumor selective inhibition of the WNT pathway
-
Turning insulin addiction and KRAS/BRCA2 co-mutations into vulnerabilities for pancreatic cancer treatment
-
Uncovering Novel Regulators of HSC Fate Control
-
Understanding tumor-immune interactions in cancer initiation and progression (Long-Term Fellowship 2022)
-
tRNA wobble modifications as drivers of the adaptive proteome in stress resistance and metastasis